Geneos Wealth Management’s Vanguard Mid-Cap Value ETF VOE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.7M | Buy |
63,297
+181
| +0.3% | +$33.8K | 0.27% | 79 |
|
|
2025
Q4 | $11.2M | Buy |
63,116
+1,181
| +2% | +$207K | 0.27% | 84 |
|
|
2025
Q3 | $10.8M | Sell |
61,935
-3,060
| -5% | -$521K | 0.27% | 85 |
|
|
2025
Q2 | $10.7M | Sell |
64,995
-70,222
| -52% | -$11.1M | 0.26% | 95 |
|
|
2025
Q1 | $21.7M | Buy |
135,217
+68,239
| +102% | +$11.2M | 0.31% | 78 |
|
|
2024
Q4 | $10.8M | Sell |
66,978
-597
| -0.9% | -$101K | 0.38% | 53 |
|
|
2024
Q3 | $11.3M | Sell |
67,575
-260
| -0.4% | -$41.3K | 0.43% | 47 |
|
|
2024
Q2 | $10.2M | Buy |
67,835
+654
| +1% | +$99.2K | 0.45% | 47 |
|
|
2024
Q1 | $10.5M | Sell |
67,181
-441
| -0.7% | -$64.7K | 0.48% | 46 |
|
|
2023
Q4 | $9.81M | Sell |
67,622
-1,134
| -2% | -$152K | 0.48% | 45 |
|
|
2023
Q3 | $9M | Buy |
68,756
+799
| +1% | +$111K | 0.46% | 42 |
|
|
2023
Q2 | $9.4M | Sell |
67,957
-9,279
| -12% | -$1.24M | 0.49% | 40 |
|
|
2023
Q1 | $10.4M | Buy |
77,236
+66,216
| +601% | +$9.19M | 0.63% | 24 |
|
|
2022
Q4 | $1.49M | Buy |
11,020
+9,005
| +447% | +$1.21M | 0.09% | 217 |
|
|
2022
Q3 | $245K | Sell |
2,015
-88
| -4% | -$11.9K | 0.02% | 554 |
|
|
2022
Q2 | $275K | Sell |
2,103
-713
| -25% | -$101K | 0.01% | 639 |
|
|
2022
Q1 | $421K | Sell |
2,816
-637
| -18% | -$93.7K | 0.02% | 584 |
|
|
2021
Q4 | $519K | Buy |
3,453
+426
| +14% | +$62.6K | 0.02% | 567 |
|
|
2021
Q3 | $428K | Sell |
3,027
-79
| -3% | -$11.2K | 0.02% | 613 |
|
|
2021
Q2 | $440K | Sell |
3,106
-7,856
| -72% | -$1.11M | 0.02% | 589 |
|
|
2021
Q1 | $1.54M | Buy |
10,962
+1,964
| +22% | +$251K | 0.04% | 327 |
|
|
2020
Q4 | $162K | Buy |
8,998
+7,847
| +682% | +$879K | 0.01% | 915 |
|
|
2020
Q3 | $114K | Buy |
1,151
+6
| +0.5% | +$608 | 0.01% | 890 |
|
|
2020
Q2 | $105K | Sell |
1,145
-102
| -8% | -$9.35K | 0.01% | 900 |
|
|
2020
Q1 | $101K | Buy |
1,247
+129
| +12% | +$13.9K | 0.01% | 834 |
|
|
2019
Q4 | $133K | Buy |
1,118
+145
| +15% | +$16.7K | 0.01% | 841 |
|
|
2019
Q3 | $109K | Buy |
973
+86
| +10% | +$9.55K | 0.01% | 863 |
|
|
2019
Q2 | $98K | Buy |
887
+97
| +12% | +$10.6K | 0.01% | 922 |
|
|
2019
Q1 | $85K | Buy |
790
+28
| +4% | +$2.94K | 0.01% | 921 |
|
|
2018
Q4 | $72K | Buy |
762
+108
| +17% | +$11.3K | 0.01% | 953 |
|
|
2018
Q3 | $74K | Buy |
654
+390
| +148% | +$44.3K | ﹤0.01% | 998 |
|
|
2018
Q2 | $29K | Sell |
264
-265
| -50% | -$29.3K | ﹤0.01% | 1302 |
|
|
2018
Q1 | $57K | Sell |
529
-51
| -9% | -$5.74K | 0.01% | 953 |
|
|
2017
Q4 | $64K | Buy |
580
+549
| +1,771% | +$59.4K | 0.01% | 906 |
|
|
2017
Q3 | $3K | Buy |
+31
| New | +$3.22K | ﹤0.01% | 1918 |
|
|
2016
Q2 | – | Sell |
-1,013
| Closed | -$88K | – | 1856 |
|
|
2016
Q1 | $88K | Buy |
+1,013
| New | +$82.6K | 0.01% | 627 |
|
Other funds holding VOE
EWA
TCIIS
Geneos Wealth Management's VOE Position: Q1 2026 in Review
Geneos Wealth Management increased its Vanguard Mid-Cap Value ETF (VOE) stake by 0.29% in Q1 2026, buying an estimated $33.8K and bringing the position to 63,297 shares worth $11.7M. The position accounts for 0.27% of the portfolio, ranked #79.
Geneos Wealth Management first reported a position in VOE in Q1 2016 and has held it in 36 quarters since. The position peaked at $21.7M in Q1 2025. 1,217 funds tracked by Wall St. Rank hold VOE as of Q1 2026.
- Geneos Wealth Management held 63,297 shares of Vanguard Mid-Cap Value ETF worth $11.7M as of Q1 2026.
- Geneos Wealth Management bought 181 Vanguard Mid-Cap Value ETF shares in Q1 2026, an estimated $33.8K.
- Vanguard Mid-Cap Value ETF made up 0.27% of Geneos Wealth Management's portfolio in Q1 2026, its #79 holding.
- Geneos Wealth Management first reported a position in Vanguard Mid-Cap Value ETF in Q1 2016 and has held it in 36 quarters since.
- Geneos Wealth Management's Vanguard Mid-Cap Value ETF position peaked at $21.7M in Q1 2025.
- 1,217 funds tracked by Wall St. Rank held Vanguard Mid-Cap Value ETF as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.